Market Data
Market Cap₹6,764.97 Cr.
52W High₹781
Current Price₹674.2
52W Low₹445
Down from 52W High13.7 %
Face Value₹10
Performance
ROCE14.6 %
ROE7.62 %
EPS (TTM)₹3.19
EPS Prev Qtr₹3.03
EPS Last Year₹-1.12
EBITDA Qtr₹39.34 Cr.
Book Value₹111
Financial Health
Debt/Equity0.02
Debt/Profit0.27
Total Assets₹1,470.866 Cr.
Promoter Holding63.85 %
Earning Power9.98 %
Valuation
Stock P/E79.04
Industry P/E40.99
Price to Book6.06
Price to Sales6.43
Graham Number₹146.12
Key Metrics
Face Value
₹2
About Nephrocare Health Services Ltd
Healthcare · Healthcare
Nephrocare Health Services Ltd is listed on NSE in the Healthcare / Healthcare sector. Face value ₹10. Market cap ₹6,764.97 Cr.
Price Chart
Strengths & Weaknesses
Strengths
- The company has a low debt-to-equity ratio of 0.02, indicating strong financial stability.
- The company has a significant promoter holding of 63.85%, suggesting strong management control and alignment of interests.
Weaknesses
- The P/E ratio of 85.84 is relatively high, suggesting the stock may be overvalued compared to peers.
- The P/B ratio of 6.58 is elevated, indicating potential overvaluation in terms of book value.
- The ROE of 7.62% is relatively low, suggesting moderate efficiency in generating returns on equity.
- The ROCE of 14.6% is modest, indicating room for improvement in capital efficiency.
Peer Comparison
| Name | CMP | P/E | Market Cap | Div Yield | NP Qtr | Qtr Profit Var% | Sales Qtr | Qtr Sales Var% | ROCE% | Debt/Eq |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | - | 60.97 | ₹1,27,421.96 Cr | 0.23% | ₹2,172 Cr | - | ₹26,429.9 Cr | - | 22.05% | 0.6 |
| Max Healthcare Institute Ltd | - | 66.77 | ₹97,411.97 Cr | 0.2% | ₹1,457.4 Cr | - | ₹8,712.05 Cr | - | 14.38% | 0.27 |
| Manipal Health Enterprises Ltd | - | - | ₹94,970.23 Cr | - | - | - | - | - | - | 1.25 |
| Aster DM Quality Care Ltd | - | 121 | ₹65,183.66 Cr | 0.4% | ₹362.82 Cr | - | ₹4,876.03 Cr | - | 12.95% | 0.17 |
| Fortis Healthcare Ltd | - | 59.91 | ₹62,782.32 Cr | 0.12% | ₹1,070.21 Cr | - | ₹9,506.15 Cr | - | 13.34% | 0.29 |
| Global Health Ltd | - | 69.27 | ₹38,550.84 Cr | - | ₹552.33 Cr | - | ₹4,683.41 Cr | - | 21.87% | 0.1 |
| Narayana Hrudayalaya Ltd | - | 45.26 | ₹37,159.95 Cr | - | ₹816.55 Cr | - | ₹9,072.4 Cr | - | 13.65% | 1.07 |
| Dr Lal Pathlabs Ltd | - | 46.81 | ₹32,548.55 Cr | 1.26% | ₹546.3 Cr | - | ₹2,890.8 Cr | - | 29.55% | 0 |
| Krishna Institute of Medical Sciences Ltd | - | 150.24 | ₹32,180.9 Cr | - | ₹194.4 Cr | - | ₹4,212.5 Cr | - | 9.66% | 1.44 |
| Poly Medicure Ltd | - | 52.64 | ₹16,587.48 Cr | 0.21% | ₹312.92 Cr | - | ₹1,997.43 Cr | - | 15.07% | 0.06 |
| Dr Agarwals Health Care Ltd | - | 107.57 | ₹15,991.79 Cr | - | ₹185.1 Cr | - | ₹2,206.68 Cr | - | 16.46% | 0.08 |
| Vijaya Diagnostic Centre Ltd | - | 82.27 | ₹15,431.94 Cr | 0.13% | ₹187.49 Cr | - | ₹857.13 Cr | - | 36.21% | 0 |
| Syngene International Ltd | - | 68.32 | ₹15,167.87 Cr | 0.33% | ₹221 Cr | - | ₹3,600.2 Cr | - | 6.95% | 0 |
| Indegene Ltd | - | 36.68 | ₹14,769.29 Cr | 0.37% | ₹400.9 Cr | - | ₹3,812.8 Cr | - | 17.45% | 0 |
| Rainbow Childrens Medicare Ltd | - | 48.85 | ₹13,947.12 Cr | 0.25% | ₹290.28 Cr | - | ₹1,820.14 Cr | - | 27.05% | 0 |
| Molbio Diagnostics Ltd | - | - | ₹13,924.73 Cr | - | - | - | - | - | - | 0.35 |
| Park Medi World Ltd | - | 38.3 | ₹11,945.05 Cr | - | ₹296.75 Cr | - | ₹1,756.29 Cr | - | 19.17% | 0.11 |
| Metropolis Healthcare Ltd | - | 24.51 | ₹11,863.54 Cr | 0.87% | ₹202.82 Cr | - | ₹1,710 Cr | - | 19.8% | 0.01 |
| Yatharth Hospital & Trauma Care Services Ltd | - | 58.5 | ₹10,596.57 Cr | - | ₹174.45 Cr | - | ₹1,334.1 Cr | - | 11.7% | 0.14 |
| Healthcare Global Enterprises Ltd | - | 446.68 | ₹10,336.94 Cr | - | ₹33.26 Cr | - | ₹2,627.35 Cr | - | 9.41% | 0.68 |
Quarterly Results
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Sales | 245.72 | 259.73 | 265.62 | 281.75 |
| ↳ QoQ Growth | - | +5.7% | +2.3% | +6.1% |
| Expenses | 205.23 | 220.73 | 237.69 | 242.41 |
| Operating Profit | 40.49 | 39 | 27.92 | 39.34 |
| OPM % | 16.48% | 15.02% | 10.51% | 13.96% |
| Other Income | 3.89 | 3.32 | 11.57 | 7.46 |
| Interest | 45 | 5.96 | 3.18 | 2.21 |
| Depreciation | 23.44 | 21.86 | 25.85 | 24.54 |
| EBITDA | 63.93 | 60.86 | 53.77 | 63.88 |
| EBITDA Margin % | 26.02% | 23.43% | 20.24% | 22.67% |
| Profit Before Tax | -0.62 | 36.36 | 33.22 | 41.03 |
| Tax % | -1,427.42% | 11.33% | 8.58% | 22.08% |
| Net Profit | -9.47 | 32.24 | 30.37 | 31.97 |
| ↳ QoQ Growth | - | +440.4% | -5.8% | +5.3% |
| EPS | -1.12 | 3.43 | 3.03 | 3.19 |
Balance Sheet
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 1.77 | 20.068 |
| Reserves | 582.35 | 1096.425 |
| Borrowings | 257.77 | 23.02 |
| Other Liabilities | 154.57 | 331.35 |
| Total Liabilities | 996.46 | 1470.866 |
| Fixed Assets | 324.05 | 516.754 |
| CWIP | 5.84 | 5.538 |
| Investments | 50.76 | 177.78 |
| Other Assets | 615.81 | 770.79 |
| Total Assets | 996.46 | 1470.866 |
Cash Flows
| Mar 2026 | |
|---|---|
| Cash from Operating Activity | 232.579 |
| Cash from Investing Activity | -410.435 |
| Cash from Financing Activity | 157.109 |
| Net Cash Flow | -20.747 |
Shareholding Pattern
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Promoters % | 63.85% | 63.85% | 63.85% |
| FIIs % | 9.3% | 9.94% | 8.78% |
| DIIs % | 8.1% | 8.64% | 9.05% |
| Public % | 5.92% | 5.08% | 5.7% |
| No. of Shareholders | 67,416 | 43,409 | 44,091 |
Major Shareholders (>1%)
- Edoras Investment Holdings Pte LtdPromoter and Promoter Group28.30%
- Vikram VuppalaPromoter and Promoter Group9.79%
- Bessemer Venture Partners TrustPromoter and Promoter Group8.66%
- Investcorp India Investments Holding LimitedPublic Shareholding6.29%
As of 2026-06-30View all shareholders →